IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,836,000
- Total 13F shares
- 95,917,514
- Share change
- +651,396
- Total reported value
- $3,316,384,149
- Put/Call ratio
- 16%
- Price per share
- $34.57
- Number of holders
- 242
- Value change
- +$34,324,785
- Number of buys
- 128
- Number of sells
- 102
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
13,146,545
|
$357,717,496 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
8.1%
from 13D/G
|
8,127,226
|
$221,141,808 | — | 30 Sep 2025 | |
| Capital Research Global Investors |
13D/G
13F
|
Company |
6%
|
5,279,675
|
$194,503,227 | -$46,897,909 | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
13D/G
|
Company |
7.3%
from 13D/G
|
6,428,339
|
$174,931,459 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.6%
|
4,922,208
|
$133,933,280 | — | 30 Sep 2025 | |
| FEDERATED HERMES, INC. |
13F
13D/G
|
Company |
3.9%
from 13D/G
|
4,625,850
|
$125,869,379 | — | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13F
13D/G
|
Company |
2.1%
from 13D/G
|
3,815,704
|
$103,825,312 | — | 30 Sep 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.7%
|
3,275,444
|
$89,124,831 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
3,240,934
|
$88,185,814 | — | 30 Sep 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.3%
|
2,900,094
|
$78,911,558 | — | 30 Sep 2025 | |
| Logos Global Management LP |
13F
|
Company |
2.6%
|
2,250,000
|
$61,222,500 | — | 30 Sep 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.5%
|
2,153,043
|
$58,584,300 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,150,033
|
$58,511,758 | — | 30 Sep 2025 | |
| Fiera Capital Corp |
13F
|
Company |
2.1%
|
1,837,967
|
$50,011,082 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.8%
|
1,580,353
|
$43,001,432 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.5%
|
1,316,991
|
$35,835,325 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
1,233,113
|
$33,553,004 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
1,109,740
|
$30,197,000 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
1.2%
|
1,056,577
|
$28,749,461 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.2%
|
1,032,999
|
$28,107,903 | — | 30 Sep 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
1.2%
|
1,012,967
|
$27,562,832 | — | 30 Sep 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.1%
|
922,695
|
$25,106,531 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
916,069
|
$24,926,241 | — | 30 Sep 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.98%
|
862,208
|
$23,460,679 | — | 30 Sep 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.86%
|
753,164
|
$20,493,592 | — | 30 Sep 2025 | |
| Redmile Group, LLC |
13F
|
Company |
0.84%
|
742,017
|
$20,190,283 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.81%
|
715,538
|
$19,469,789 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
709,861
|
$19,315,318 | — | 30 Sep 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
625,704
|
$17,025,406 | — | 30 Sep 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.64%
|
558,048
|
$15,184,486 | — | 30 Sep 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.61%
|
539,923
|
$14,691,305 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.57%
|
497,048
|
$13,524,677 | — | 30 Sep 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.56%
|
488,956
|
$13,304,493 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.47%
|
409,619
|
$11,145,000 | — | 30 Sep 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.47%
|
408,452
|
$11,114,000 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.46%
|
405,645
|
$11,037,600 | — | 30 Sep 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.46%
|
400,000
|
$10,884,000 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.43%
|
380,311
|
$10,348,262 | — | 30 Sep 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.42%
|
371,825
|
$10,117,358 | — | 30 Sep 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.4%
|
350,000
|
$9,523,500 | — | 30 Sep 2025 | |
| AXA Investment Managers S.A. |
13F
|
Company |
0.37%
|
325,513
|
$8,857,209 | — | 30 Sep 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.34%
|
299,032
|
$8,136,661 | — | 30 Sep 2025 | |
| GENERAL AMERICAN INVESTORS CO INC |
13F
|
Company |
0.32%
|
280,261
|
$7,625,902 | — | 30 Sep 2025 | |
| Iron Triangle Partners LP |
13F
|
Company |
0.31%
|
270,000
|
$7,346,700 | — | 30 Sep 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.3%
|
263,693
|
$7,175,087 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.29%
|
250,381
|
$6,812,867 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
248,900
|
$6,772,555 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.28%
|
243,008
|
$6,612,220 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.27%
|
235,425
|
$6,405,914 | — | 30 Sep 2025 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
233,412
|
$6,346,472 | — | 30 Sep 2025 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q4 2025
As of 31 Dec 2025,
IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by
242 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
95,917,514 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., JANUS HENDERSON GROUP PLC, Capital Research Global Investors, VANGUARD GROUP INC, STATE STREET CORP, BAKER BROS. ADVISORS LP, FEDERATED HERMES, INC., Logos Global Management LP, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
242
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
221
Q4 2025 holders
242
Holder diff
21
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.